The Federal Government through the National Primary Health Care Development Agency (NPHCDA), announced its distribution plan for the Covid-19 vaccine deployment in Nigeria. The FG disclosed in a publication alongside Nigeria Centre For Disease Control (NCDC) on Saturday that the rate of infection per state/region would determine priority in the distribution of vaccines. The NPHCDA revealed that all states will initially receive 4,000 vaccines during the first phase, as the FG urges that healthcare workers and the elderly be made priority in receiving vaccination. According to NAN, based on infection rates, the vaccines distributed to states would be: Kano State 3,557; Lagos 3,131; Katsina 2,361; Kaduna 2,074; Bauchi 1,900; Oyo 1,848; Rivers 1,766; Jigawa 1,712; Niger 1,558; Ogun 1,473; Sokoto 1,468; Benue 1,423; Borno 1,416; Anambra 1,379; Zamfara 1,336; Delta 1,306 Kebbi 1,268; Imo 1,267; Ondo 1,228; Akwa Ibom 1,161; Adamawa 1,129; Edo 1,104; Plateau 1,089; Enugu 1,088; Osun 1,032; Kogi 1,030; Cross River 1,023; Abia 955; Gombe 908; Yobe 842; Ekiti 830; Taraba 830; Kwara 815; Ebonyi 747; Bayelsa 589; FCT 695; Nasarawa 661. NPHCDA added that the vaccines would be given from January to February in its first phase, as the FG targets vaccinating 40% of Nigerians by 2021 and 70% by 2022. What you should know Nairametrics reported last week that the FG stated NPHCDA with its partners, is working to fix healthcare value chain roadblocks that may affect the fair distribution of Covid-19 vaccines. NPHCDA, working with partners, is currently assessing the infrastructural gaps in terms of logistics for cold chain maintenance, storage, supply and distribution. We are also working with the Aviation Ministry to ensure strict enforcement of COVID-19 protocols at the local and international wings of airports across the country, taking cognisance of the high transmissibility of the new strain of the virus already confirmed in many countries,” said Minister of State for Health, Sen. Olorunnimbe Mamora. BioNTech also disclosed that they will supply up to 50 million doses of their COVID-19 vaccine to Africa, starting from March 2021.